Showing 43,901 - 43,915 results of 43,915 for search '(( 09 ((0 decrease) OR (a decrease)) ) OR ( 20 ((teer decrease) OR (nn decrease)) ))', query time: 0.88s Refine Results
  1. 43901

    Image_4_Epidemic Trends in High Tuberculosis Burden Countries During the Last Three Decades and Feasibility of Achieving the Global Targets at the Country Level.TIF by Cheng Ding (34937)

    Published 2022
    “…</p>Results<p>The incidence and mortality decreased in most of the HBCs. The AAPCs of incidence ranged between −4.0 (Indonesia) and −0.2% (DR Congo) (all p < 0.05). …”
  2. 43902

    Image_1_Epidemic Trends in High Tuberculosis Burden Countries During the Last Three Decades and Feasibility of Achieving the Global Targets at the Country Level.TIF by Cheng Ding (34937)

    Published 2022
    “…</p>Results<p>The incidence and mortality decreased in most of the HBCs. The AAPCs of incidence ranged between −4.0 (Indonesia) and −0.2% (DR Congo) (all p < 0.05). …”
  3. 43903

    Image_3_Epidemic Trends in High Tuberculosis Burden Countries During the Last Three Decades and Feasibility of Achieving the Global Targets at the Country Level.TIF by Cheng Ding (34937)

    Published 2022
    “…</p>Results<p>The incidence and mortality decreased in most of the HBCs. The AAPCs of incidence ranged between −4.0 (Indonesia) and −0.2% (DR Congo) (all p < 0.05). …”
  4. 43904

    Image_2_Epidemic Trends in High Tuberculosis Burden Countries During the Last Three Decades and Feasibility of Achieving the Global Targets at the Country Level.TIF by Cheng Ding (34937)

    Published 2022
    “…</p>Results<p>The incidence and mortality decreased in most of the HBCs. The AAPCs of incidence ranged between −4.0 (Indonesia) and −0.2% (DR Congo) (all p < 0.05). …”
  5. 43905

    HLA high-resolution typing by next-generation sequencing in Pandemrix-induced narcolepsy by Alexander Lind (5221088)

    Published 2019
    “…Indeed, this extended haplotype was found in 30/31 patients (96.8%) and 178/636 GP (28.0%). In total, 15 alleles, four extended haplotypes, and six genotypes were found to be increased or decreased in frequency among NT1 patients compared to GP. …”
  6. 43906

    Datasheet3_Catheter ablation vs. drug therapy in the treatment of atrial fibrillation patients with heart failure: An update meta-analysis for randomized controlled trials.docx by Chun Lin (680865)

    Published 2023
    “…According to the meta-analysis, catheter ablation significantly reduced all-cause mortality compared with drug therapy [9.2% vs. 14.1%, OR: 0.62, (95% CI: 0.47–0.82), P = 0.0007, I<sup>2</sup><sup> </sup>= 0%], improved LVEF [MD: 5.65%, (95% CI: 3.32–7.98), P < 0.00001, I<sup>2</sup><sup> </sup>= 86%], reduced AF recurrence [41.6% vs. 61.9%, OR: 0.23, (95% CI: 0.11–0.48), P < 0.0001, I<sup>2</sup><sup> </sup>= 82%], decreased the MLHFQ score [MD: −6.38, (95% CI: −11.09 to −1.67), P = 0.008, I<sup>2 </sup>= 64%] and increased 6MWD [MD: 17.55, (95% CI: 15.77–19.33), P < 0.0001, I<sup>2</sup><sup> </sup>= 37%]. …”
  7. 43907

    Table1_Catheter ablation vs. drug therapy in the treatment of atrial fibrillation patients with heart failure: An update meta-analysis for randomized controlled trials.docx by Chun Lin (680865)

    Published 2023
    “…According to the meta-analysis, catheter ablation significantly reduced all-cause mortality compared with drug therapy [9.2% vs. 14.1%, OR: 0.62, (95% CI: 0.47–0.82), P = 0.0007, I<sup>2</sup><sup> </sup>= 0%], improved LVEF [MD: 5.65%, (95% CI: 3.32–7.98), P < 0.00001, I<sup>2</sup><sup> </sup>= 86%], reduced AF recurrence [41.6% vs. 61.9%, OR: 0.23, (95% CI: 0.11–0.48), P < 0.0001, I<sup>2</sup><sup> </sup>= 82%], decreased the MLHFQ score [MD: −6.38, (95% CI: −11.09 to −1.67), P = 0.008, I<sup>2 </sup>= 64%] and increased 6MWD [MD: 17.55, (95% CI: 15.77–19.33), P < 0.0001, I<sup>2</sup><sup> </sup>= 37%]. …”
  8. 43908

    Datasheet2_Catheter ablation vs. drug therapy in the treatment of atrial fibrillation patients with heart failure: An update meta-analysis for randomized controlled trials.docx by Chun Lin (680865)

    Published 2023
    “…According to the meta-analysis, catheter ablation significantly reduced all-cause mortality compared with drug therapy [9.2% vs. 14.1%, OR: 0.62, (95% CI: 0.47–0.82), P = 0.0007, I<sup>2</sup><sup> </sup>= 0%], improved LVEF [MD: 5.65%, (95% CI: 3.32–7.98), P < 0.00001, I<sup>2</sup><sup> </sup>= 86%], reduced AF recurrence [41.6% vs. 61.9%, OR: 0.23, (95% CI: 0.11–0.48), P < 0.0001, I<sup>2</sup><sup> </sup>= 82%], decreased the MLHFQ score [MD: −6.38, (95% CI: −11.09 to −1.67), P = 0.008, I<sup>2 </sup>= 64%] and increased 6MWD [MD: 17.55, (95% CI: 15.77–19.33), P < 0.0001, I<sup>2</sup><sup> </sup>= 37%]. …”
  9. 43909

    Datasheet4_Catheter ablation vs. drug therapy in the treatment of atrial fibrillation patients with heart failure: An update meta-analysis for randomized controlled trials.docx by Chun Lin (680865)

    Published 2023
    “…According to the meta-analysis, catheter ablation significantly reduced all-cause mortality compared with drug therapy [9.2% vs. 14.1%, OR: 0.62, (95% CI: 0.47–0.82), P = 0.0007, I<sup>2</sup><sup> </sup>= 0%], improved LVEF [MD: 5.65%, (95% CI: 3.32–7.98), P < 0.00001, I<sup>2</sup><sup> </sup>= 86%], reduced AF recurrence [41.6% vs. 61.9%, OR: 0.23, (95% CI: 0.11–0.48), P < 0.0001, I<sup>2</sup><sup> </sup>= 82%], decreased the MLHFQ score [MD: −6.38, (95% CI: −11.09 to −1.67), P = 0.008, I<sup>2 </sup>= 64%] and increased 6MWD [MD: 17.55, (95% CI: 15.77–19.33), P < 0.0001, I<sup>2</sup><sup> </sup>= 37%]. …”
  10. 43910

    Datasheet1_Catheter ablation vs. drug therapy in the treatment of atrial fibrillation patients with heart failure: An update meta-analysis for randomized controlled trials.docx by Chun Lin (680865)

    Published 2023
    “…According to the meta-analysis, catheter ablation significantly reduced all-cause mortality compared with drug therapy [9.2% vs. 14.1%, OR: 0.62, (95% CI: 0.47–0.82), P = 0.0007, I<sup>2</sup><sup> </sup>= 0%], improved LVEF [MD: 5.65%, (95% CI: 3.32–7.98), P < 0.00001, I<sup>2</sup><sup> </sup>= 86%], reduced AF recurrence [41.6% vs. 61.9%, OR: 0.23, (95% CI: 0.11–0.48), P < 0.0001, I<sup>2</sup><sup> </sup>= 82%], decreased the MLHFQ score [MD: −6.38, (95% CI: −11.09 to −1.67), P = 0.008, I<sup>2 </sup>= 64%] and increased 6MWD [MD: 17.55, (95% CI: 15.77–19.33), P < 0.0001, I<sup>2</sup><sup> </sup>= 37%]. …”
  11. 43911

    Dataset: Increased Organic Carbon Burial in Northern Florida Mangrove-Salt Marsh Transition Zones by Derrick Vaughn (7900301)

    Published 2021
    “…Higher amino acid concentrations in mangrove soils relative to mangrove biomass (1.8-2.3 mmol gC<sup>-1</sup> vs. 0.2-0.9 mmol gC<sup>-1</sup>) and lower C/N indicated these mangrove sites receive higher algal inputs than the transition and salt marsh sites, attributed to greater tidal inundation in the mangrove sites given their position near the shoreline. …”
  12. 43912

    Dataset used in the manuscript. by Saeun Park (20410160)

    Published 2024
    “…Caregivers had more severe symptoms of depression and/or anxiety if they experienced greater changes in living situations or decreases in physical activity (CESD-20: β = 3.35, 95% CI [1.00, 5.70], p = .01), food insecurity (HSCL-25: β = 3.25, 95% CI [0.41, 6.10], p = .03, CESD-25: β = 3.09, 95% CI [0.79, 5.39], p = .01), and domestic violence (HSCL-25: β = 3.82, 95% CI [0.94, 6.70], p = .01) during COVID-19. …”
  13. 43913
  14. 43914

    Hypokalemia, Its Contributing Factors and Renal Outcomes in Patients with Chronic Kidney Disease by Hsiao-Han Wang (429124)

    Published 2013
    “…</p><p>Results</p><p>The mean age was 62.4 years, mean sK level was 4.2±0.5 mEq/L and average eGFR was 40.6 ml/min per 1.73 m<sup>2</sup>. …”
  15. 43915

    Harmonic Shears for Skeletonized Internal Thoracic Arteries and Great Saphenous Vein Harvesting by Corrado Cavozza (5496989)

    Published 2018
    “…<i><a href="https://doi.org/10.1016/j.athoracsur.2009.09.061">Ann Thorac Surg. 2010;89(2):403-408</a></i>.…”